5 Healthcare Stocks On Fire This Week Five healthcare stocks have emerged as standout performers, posting remarkable week-on-week momentum gains according to the latest Benzinga Edge Ranking report. Benzinga · Aug 21, 2025
Why Is Soligenix Stock Soaring On Monday? Soligenix, Inc. (NASDAQ:SNGX) stock is higher on Monday after the U.S. Food and Drug Administration granted orphan drug designation to dusquetide, the active ingredient in SGX945, for Behçet’s Disease. Benzinga · Aug 18, 2025
Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial Soligenix Inc. (NASDAQ:SNGX) shares surged on Thursday as the company announced positive results from its Phase 2a proof-of-concept study of SGX945 (dusquetide) in Behçet’s disease, a rare and chronic inflammatory condition. Benzinga · Jul 31, 2025
SNGX: Bivalent Filovirus Vaccine Candidate Provides 100% Protection in Non-Human Primates… By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Benzinga · Jul 2, 2022
SNGX: Phase 2a Trial of SGX302 in Psoriasis to Initiate in Second Half of 2022… By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Benzinga · May 24, 2022
Soligenix's COVID-19 Vaccine Candidate As Booster Neutralizes Delta, Omicron Variants Soligenix Inc (NASDAQ:SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non-human primates (NHPs). The data demonstrated rapid enhancement of neutralizing antibody responses to SARS-CoV-2, including against Delta and Omicron variants. The NHPs had been double vaccinated with an adenovirus vaccine for COVID-19 seven months… Benzinga · Mar 17, 2022